S(-) Amlodipine-Hemi L(+)-Tartarate Mono Dmso Solvate置于氨,水体系中,用 二氯甲烷 用作溶剂,化学反应 0.5H,以92%的收率获得左旋氨氯地平 参考文献:Process For The Preparation Of S(-)-Amlodipine-L(+)-Hemitartrate 标题:Process For The Preparation Of S(-)-Amlodipine-L(+)-Hemitartrate 摘要:本发明涉及一种从rs氨氯地平基础物质中利用l(+)酒石酸在有机溶剂如二甲基亚砜的存在下制备[s(-)氨氯地平-L(+)-半酒石酸盐]的过程.
专利信息
专利号:US-10973847-B2 优先权日:2017-06-30 标题 :Core-to-surface polymerization for the synthesis of star polymers and uses thereof 发明人:JOHNSON JEREMIAH A; GOLDER MATTHEW R 权利人:MASSACHUSETTS INST TECHNOLOGY 摘要:Disclosed are methods, compositions, reagents, systems, and kits to prepare star polymers, as well as compositions and uses thereof. Various embodiments show that synthesis of these polymers contain low metal concentration to provide polymers for diverse biomedical applications including in vivo applications.
专利号:WO-2025101716-A1 优先权日:2023-11-07 标题:Processes for synthesis of trifunctionalized sulfur(vi) compounds 发明人:LOPCHUK JUSTIN; SHULTZ ZACHARY; ATHAWALE PARESH 权利人:H LEE MOFFITT CANCER CT & RES 摘要:This disclosure describes processes for the asymmetric synthesis of trifunctionalized sulfur(VI) containing organic compounds of Formula I and Formula VI, as well as compounds of Formula I and Formula VI prepared by the processes described.
专利号:US-6603006-B2 优先权日:1998-10-26 标题:Intermediate for the synthesis of amlodipine, a process for the preparation thereof and corresponding use 发明人:COPPI LAURA; GASANZ GUILLEN YOLANDA; CAMPON PARDO JULIO 权利人:ESTEVE QUIMICA SA 摘要:An intermediate for the synthesis of amlodipine, a process for the preparation thereof and the corresponding use are disclosed. The intermediate is ethyl 3-amino-4-(2-(phthalimido)ethoxy)crotonate and is of formula III:The process for the preparation thereof comprises reacting the acetoacetate of formula:with ammonium acetate; and the use thereof is for the preparation of the compound of formula:the process being conducted by reacting ethyl 3-amino-4-[2-(phthalimido)ethoxy]crotonate with a benzylidene derivative.
专利号:US-2008287407-A1 优先权日:2003-12-10 标题 :Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use 发明人:GARVEY DAVID S; FANG XINQIN; KHANAPURE SUBHASH P; RANATUNGA RAMANI R; WEY SHIOW-JYI 权利人:NITROMED INC 摘要:The invention describes novel nitrosated and/or nitrosylated pyruvate compounds and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated and/or nitrosylated pyruvate compound, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one pyruvate compound and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one pyruvate compound, that is optionally nitrosated and/or nitrosylated, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating diseases resulting from oxidative stress, diabetes, reperfusion injury following ischemia, preservation of tissues, organs, organ parts and/or limbs.
专利号:EP-3967330-A1 优先权日:2020-09-10 标 题:Methods for the synthesis of bioactivated metal nanocluster and their medical application 发明人:MARCHI VALÉRIE; CHIECHIO REGINA MARIA; EVEN-HERNANDEZ PASCALE 权利人:UNIV RENNES; CENTRE NAT RECH SCIENT; INSTITUT NAT DES SCIENCES APPLIQUEES DE RENNES; ECOLE NAT SUPERIEURE DE CHIMIE DE RENNES 摘要:The present invention relates to a bioactivated metal nanocluster comprising a mixture of ligands linked to a fluorescent metallic nanocluster, their synthesis methods, and their medical applications.
专利号:US-2024368164-A1 优先权日:2021-04-28 标 题 :Purine nucleosides, their intermediates, and methods of preparation thereof 发明人:RAVI RAMA SURESH; JACOBSON KENNETH A; POE RUSSELL BIRCH 权利人:ASTROCYLE PHARMACEUTICALS INC; US HEALTH 摘要:The present invention provides purine nucleoside analog compounds and methods of use thereof for treatment of certain injuries, disorders and conditions, for example brain injuries such as stroke or traumatic brain injuries. The present invention further provides methods of synthesizing such compounds, and intermediates useful in the synthesis of such compounds.
1: Qi Y, Zhang X. Determination of enantiomeric impurity of levamlodipine besylate bulk drug by capillary electrophoresis using carboxymethyl-β-cyclodextrin. Cell Biochem Biophys. 2014 Dec;70(3):1633-7. doi: 10.1007/s12013-014-0106-2. doi: 10.1111/j.1755-5949.2012.00323.x. doi: 10.1111/cns.12057. doi: 10.1038/hr.2015.155. Epub 2016 Jan 14. doi: 10.1016/j.bpj.2008.12.3965. 6: Xiao H, Fu X, Liang S, Li Y, Bao JJ, Zhang Y. An approach to the determination of the enantiomeric excess at the extreme case by capillary electrophoresis. J Chromatogr A. 2015 Aug 21;1408:250-4. doi: 10.1016/j.chroma.2015.07.006. Epub 2015 Jul 4. doi: 10.1016/j.msec.2016.03.115. Epub 2016 Apr 11. doi: 10.3969/j.issn.1672-7347.2012.05.005. Chinese. doi: 10.5414/CP202998.
合成参考文献
摘要: 参考文献:10.1186/s12902-018-0249-z 摘要:Duan L, Shen R, Song L, Liao Y, Zheng H. A novel chimeric CYP11B2/CYP11B1 combined with a new p.L340P CYP11B1 mutation in a patient with 11OHD: case report. BMC Endocrine Disorders. 2018 Apr 27;18(1):23. doi: 10.1186/s12902-018-0249-z.